Colgate Palmolive (CL) EBIT (2009 - 2026)

Colgate Palmolive's EBIT history runs 18 years deep, the most recent figure standing at $964.0 million for Q1 2026.

• On a quarterly basis, EBIT fell 10.41% year-over-year to $964.0 million in Q1 2026; TTM through Mar 2026 was $3.2 billion, a 25.63% decrease from a year earlier, with the FY2025 full-year figure at $3.3 billion, down 22.54% from the prior year.
• EBIT grew to $964.0 million in Q1 2026 per CL's latest filing, from $92.0 million in the prior quarter.
• Across five years, EBIT topped out at $1.1 billion in Q2 2024 and bottomed at $92.0 million in Q4 2025.
• The 5-year median for EBIT is $1.0 billion (2023), against an average of $906.8 million.
• Across the five-year window, EBIT soared 430.69% in 2023 and slumped 91.35% in 2025, its largest moves.
• Year by year, EBIT stood at $202.0 million in 2022, then surged by 430.69% to $1.1 billion in 2023, then fell by 0.84% to $1.1 billion in 2024, then slumped by 91.35% to $92.0 million in 2025, then jumped by 947.83% to $964.0 million in 2026.
• Per Business Quant, the three latest CL EBIT figures stand at $964.0 million (Q1 2026), $92.0 million (Q4 2025), and $1.1 billion (Q3 2025).